Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors-Reference-Cited by-同舟云学术

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

Published:2020-12 Issue:3 Volume:159 Page:811-819
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Landolfo C.^ORCID,Achten E.T.L.,Ceusters J.,Baert T.^ORCID,Froyman W.^ORCID,Heremans R.^ORCID,Vanderstichele A.^ORCID,Thirion G.,Van Hoylandt A.,Claes S.,Oosterlynck J.,Van Rompuy A.S.^ORCID,Schols D.^ORCID,Billen J.^ORCID,Van Calster B.^ORCID,Bourne T.^ORCID,Van Gorp T.^ORCID,Vergote I.^ORCID,Timmerman D.^ORCID,Coosemans A.^ORCID

Funder

Kom op tegen Kanker

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Centralisation of services for gynaecological cancer;Woo;Cochrane Database Syst. Rev.,2012

2. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study;Froyman;Lancet Oncol.,2019

3. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors;Engelen;Gynecol. Oncol.,2000

4. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125;Van Calster;J. Natl. Cancer Inst.,2007

5. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas;Drapkin;Cancer Res.,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-modality deep learning model reaches high prediction accuracy in the diagnosis of ovarian cancer;iScience;2024-04

2. Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors;2024-03-15

3. Clinical Significance of the Combination of Serum HE4 Levels, Hemoglobin-to-Red Cell Distribution Width Ratio, and CT Imaging for the Pretreatment Assessment of Adnexal Masses;Journal of Cancer;2023

4. Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study;Cancers;2022-03-31

5. Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer;Disease Markers;2022-03-01